1st Quarter - Report
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JORDAN CHAPMAN | — |
Medicare/Medicaid MMM
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JORDAN CHAPMAN | — |
Taxation/Internal Revenue Code TAX
Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JORDAN CHAPMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.